Cargando…
Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
Autores principales: | Sykova, Eva, Cizkova, Dasa, Kubinova, Sarka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582316/ https://www.ncbi.nlm.nih.gov/pubmed/34778276 http://dx.doi.org/10.3389/fcell.2021.770243 |
Ejemplares similares
-
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
por: Sykova, Eva, et al.
Publicado: (2021) -
Regenerative medicine for the treatment of spinal cord injury: more than just promises?
por: Pêgo, Ana Paula, et al.
Publicado: (2012) -
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
por: Chen, Qiao Yi, et al.
Publicado: (2021) -
Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
por: Wang, Ke, et al.
Publicado: (2021) -
Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis
por: Amorós, Mariana A., et al.
Publicado: (2022)